DEXTENZA Therapy for Treatment of Allergic Conjunctivitis
Status:
Not yet recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This prospective, open-label, single-center, randomized, investigator-sponsored clinical
study seeks to compare patient-reported and clinical outcomes with DEXTENZA versus topical
steroid or antihistamine treatment in patients with allergic conjunctivitis